Abstract: Provided is a cascaded FMCW radar, and more particularly, to a cascaded FMCW radar with a synchronized PLL. The cascaded FMCW radar includes a crystal oscillator generating a reference frequency signal having low-frequency characteristics, a cascade-array transceiver chip generating an output signal having high-frequency characteristics using the reference frequency signal through a signal generator provided therein, and an antenna transmitting the generated output signal to the outside in the form of an electromagnetic wave or receiving the electromagnetic wave from the outside.

Abstract: The present disclosure provides autotaxin (ATX) inhibitor compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for inhibiting ATX. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.

Abstract: Disclosed are a binder composition for an all-solid-state secondary battery, including a copolymer including a conjugated diene-based monomer, an aromatic vinyl-based monomer, and an ethylenically unsaturated acid monomer, a trithiocarbonate-based compound, a mercaptan-based compound, and a solvent, wherein a weight average molecular weight (Mw) of the copolymer is 50,000 to 200,000, and a molecular weight distribution (Mw/Mn) is 1 to 5, a method of preparing the same, a slurry composition for a cathode or a solid electrolyte including the same, and a secondary battery manufactured therefrom.

Abstract: Disclosed are a binder for a secondary battery anode including styrene-butadiene-based rubber with a core-shell structure and nitrile-butadiene-based rubber with a gel content of 15% or more, wherein a weight ratio of the styrene-butadiene-based rubber and the nitrile-butadiene-based rubber is 65:35 to 99:1, an anode mixture for a secondary battery, and an anode and a secondary battery including the same.

Abstract: The present disclosure provides autotaxin (ATX) inhibitor compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for inhibiting ATX. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: An iris image acquisition system for expanding an iris recognition range is proposed. The iris image acquisition system for expanding the iris recognition range enables that a direction, zoom, and focusing of an iris photographing camera for photographing an iris image of a distant subject are controlled quickly and easily without high-level information processing and arithmetic processing.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: The present disclosure provides adenosine receptor (e.g., A2A and/or A1 receptor) antagonist compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for modulating (e.g., inhibiting or antagonizing) A2A and/or A1 receptor in a biological system. The compounds and compositions find use in various therapeutic applications including the treatment of cancer and in immuno-oncology. The compounds and compositions find use in various therapeutic applications including the treatment of central nervous system or neurodegenerative diseases, such as Parkinson’s disease.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: An FMCW radar transmission and reception apparatus radiates, via a transmission antenna, a beat frequency signal of a frequency modulation continuous wave (FMCW) and then receives, via a reception antenna, a reflected signal obtained from the radiated frequency modulation continuous wave (FMCW) signal that is reflected by a target and returns, wherein the frequency of a beat signal of a frequency modulation continuous wave (FMCW) radar can be effectively adjusted by configuring a plurality of phase locked loops (PLLs) used in a transmitter and a receiver, and using the same reference oscillation signal for the plurality of PLLs.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: The present invention provides novel compounds of chemical formula 1, optical isomers of the compounds, or a pharmaceutically acceptable salts of the compounds, or the optical isomers. The compounds, isomers, and salts exhibits excellent activity as GLP-1 receptor agonists. Particularly, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used therapeutic agents for metabolic diseases. In addition, they exhibits excellent pharmacological safety for cardiovascular systems.

Abstract: An iris image acquisition system for expanding an iris recognition range is proposed. The iris image acquisition system for expanding the iris recognition range enables that a direction, zoom, and focusing of an iris photographing camera for photographing an iris image of a distant subject are controlled quickly and easily without high-level information processing and arithmetic processing.

Abstract: The present disclosure provides phosphodiesterase 5 (PDE-5) and/or phosphodiesterase 6 (PDE-6) inhibitor compounds and compositions including said compounds. In some embodiments, said compounds are nitrogen oxide (NO) donating PDE-5 and/or -6 inhibitor compounds that include a nitrogen oxide-containing donor substituent attached to a benzenesulfonamide group. The compounds can provide dual functionality for increasing protein kinase G (PKG) activity by inhibiting PDE-5 and PDE-6, and/or stimulating guanylate cyclase (sGC) via donation of nitrogen oxide (NO) from the donor substituent of the compound. The present disclosure also provides methods of using said compounds and compositions for inhibiting PDE-5 and/or -6 and increasing activity of protein kinase G (PKG). The compounds and compositions find use in therapeutic applications including in the treatment of a variety of eye diseases.

Abstract: Disclosed is an electrochromic device including an electrolyte layer having first and second surfaces directed in opposite directions, an electrochromic layer provided on the first surface of the electrolyte layer, a counter electrode layer provided on the second surface of the electrolyte layer, a first transparent electrode layer provided on a surface opposite to the electrolyte layer based on the electrochromic layer, and a second transparent electrode layer provided on a surface opposite to the electrolyte layer based on the counter electrode layer, in which the first and second transparent electrode layers are each provided as a composite layer in which an oxide-based electrode layer made of a material selected from a group consisting of AZO, FTO, and ITO and a metal-based electrode layer made of a material selected from a group consisting of nanowires (AgNWs), PEDOT:PSS, graphene, and a metal mesh are laminated.

Abstract: The present disclosure relates to a method for manufacturing a flexible electrochromic device, and more particularly, to a method for manufacturing a flexible electrochromic device that bonds an electrochromic part and a counter electrode part while solidifying a wet-coated electrolyte with ultraviolet rays, thereby being capable of eliminating the possibility of bubble generation in the electrolyte and improving transmittance characteristics and durability.

Abstract: The present disclosure provides autotaxin (ATX) inhibitor compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for inhibiting ATX. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.

Abstract: Provided is a pyrolysis gasification apparatus for solid refuse fuel. The apparatus includes: a superheated steam housing formed in a cylindrical shape and installed in a horizontal direction, in which superheated steam is injected into the superheated steam housing; a screw casing formed in a tubular shape extending from one end to the other end inside the superheated steam housing and installed in the horizontal direction inside the superheated steam housing, in which solid refuse fuel (SRF) is introduced into the screw casing; a conveying screw with a plurality of screw blades on an outer peripheral surface, the conveying screw being installed inside the screw casing in the horizontal direction and rotating to convey the solid refuse fuel; and a superheated steam supplier for supplying superheated steam into the superheated steam housing, in which the superheated steam may move through a movement pat.

Abstract: The present invention relates to phthalazinone derivatives, including pharmaceutical compositions and for the preparation of phthalazinone derivatives. And more particularly the present invention provided a pharmaceutical composition of phthalazinone derivatives for inhibiting activity of the Poly(ADP-riboside) polymerase enzyme.